HAVA
NASDAQ · N/A
Harvard Ave Acquisition-Cl A
$10.26
+0.02 (+0.20%)
Open$10.25
Previous Close$10.24
Day High$10.26
Day Low$10.24
52W High$10.24
52W Low$9.87
Volume—
Avg Volume156.0K
Market Cap211.90M
P/E Ratio70.80
EPS$0.15
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.03M | 196.60M | 211.78M |
| Net Income | 8.69M | 7.47M | 7.70M |
| Profit Margin | 4.0% | 3.8% | 3.6% |
| EBITDA | 14.09M | 11.42M | 12.03M |
| Free Cash Flow | 7.43M | 6.90M | 7.76M |
| Rev Growth | +5.0% | -0.4% | +4.7% |
| Debt/Equity | 0.54 | 0.45 | 0.54 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.07 | -3.94% | — | 1.28B |
| PICS | Pics Nv | $8.97 | +6.41% | 4.6 | 1.18B |
| DMII | Drugs Made In America Acquis | $10.19 | +0.00% | 49.9 | 649.10M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.19% | 42.2 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.27 | +0.00% | 41.3 | 586.93M |